Physician profile
Nancy D Hooks
NPI 1174896245
$1,723.53
in general payments reported to CMS, 2019-2025
19 companies · $447 in 2025
The $447 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $536 · 2022: $349 · 2023: $63.54 · 2024: $328 · 2025: $447.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $839.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $839.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $463.94 | 2022-2025 | Wegovy, Ozempic |
| Astrazeneca Pharmaceuticals LP | $296.11 | 2021-2022 | |
| Sequel Med Tech, LLC | $152.63 | 2025 | Twiist |
| Lilly USA, LLC | $82.86 | 2021-2024 | Jardiance, Zepbound |
| Teva Pharmaceuticals USA, INC. | $80.72 | 2021 | |
| Grt US Holding, INC. | $79.59 | 2022 | |
| Alexion Pharmaceuticals, INC. | $71.89 | 2024 | Ultomiris |
| Abiomed | $71.59 | 2024 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.16 | 2021 | |
| Boston Scientific Corporation | $61.75 | 2022-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $61.44 | 2022 | |
| Abbott Laboratories | $57.05 | 2021-2024 | Freestyle Libre, Eterna |
| Sanofi-Aventis U.S. LLC | $50.32 | 2021-2022 | |
| Amgen INC. | $36.84 | 2024-2025 | Repatha, Otezla |
| Medtronic, INC. | $32.90 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $18.29 | 2025 | Korlym |
| Merck Sharp & Dohme LLC | $16.10 | 2021 | |
| Insulet Corporation | $15.77 | 2025 | Omnipod |
| Xeris Pharmaceuticals, INC. | $11.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Hooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.